Strattera patient exposures and adherence in the United Kingdom, Germany, the Netherlands, and Sweden: 2016 Bi-annual assessment report. (B4Z-MC-B025)

First published 29/09/2015

Last updated 23/04/2024

EU PAS number:

EUPAS10786

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

B025 PASS

English (326 KB - PDF)View document

Study results

B025 PASS_Final study report_Abstract

English (99.7 KB - PDF)View document

Study report

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

Conflicts of interest of investigators

B025 PASS_Final study report

English (602.53 KB - PDF)View document

Strattera patient exposures and adherence in the United Kingdom, Germany, the Netherlands, and Sweden: 2016 Bi-annual assessment report. (B4Z-MC-B025)

Secondary tabs

Share this page